{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:29:45Z","timestamp":1779229785398,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104000"],"award-info":[{"award-number":["82104000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bmc.2023.117456","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T20:55:25Z","timestamp":1692737725000},"page":"117456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Design and synthesis of multivalent drug delivery system with CA IX inhibitors as ligands"],"prefix":"10.1016","volume":"93","author":[{"given":"Mengyuan","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiwen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117456_b0005","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1021\/acsomega.1c05671","article-title":"Hypoxia-activated albumin-binding exatecan prodrug for cancer therapy","volume":"7","author":"Cheng","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2023.117456_b0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13046-016-0335-x","article-title":"Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations","volume":"35","author":"Jensen","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.bmc.2023.117456_b0015","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1158\/1078-0432.CCR-10-1354","article-title":"Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase i inhibitor","volume":"16","author":"Pastorino","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2023.117456_b0020","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1021\/acsmedchemlett.0c00031","article-title":"Folate receptor targeting and cathepsin B-sensitive drug delivery system for selective cancer cell death and imaging","volume":"11","author":"Jin","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117456_b0025","doi-asserted-by":"crossref","unstructured":"Huang B, Desai A, Tang S, Thomas TP, Baker JR Jr, The Synthesis of a c(RGDyK) Targeted SN38 prodrug with an indolequinone structure for bioreductive drug release. Organic Lett. 2010;12 (7):1384-1387.","DOI":"10.1021\/ol1002626"},{"key":"10.1016\/j.bmc.2023.117456_b0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/clinchem\/35.5.755","article-title":"Current concepts in proteinuria","volume":"35","author":"Waller","year":"1989","journal-title":"Clin Chem"},{"key":"10.1016\/j.bmc.2023.117456_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121820","article-title":"In vivo therapeutic effects of small molecule-drug conjugates enhanced by Fc grafting","volume":"290","author":"Zheng","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bmc.2023.117456_b0040","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1021\/acs.jmedchem.1c00003","article-title":"Enhancing the pharmacokinetics and antitumor activity of an \u03b1-amanitin-based small-molecule drug conjugate via conjugation with an Fc domain","volume":"64","author":"Gallo","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117456_b0045","unstructured":"Front Matter. In Fragment\u2010based Approaches in Drug Discovery, 2006."},{"key":"10.1016\/j.bmc.2023.117456_b0050","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1021\/acs.bioconjchem.2c00335","article-title":"Multivalent ligand-nanoparticle conjugates amplify reactive oxygen species second messenger generation and enhance epidermal growth factor receptor phosphorylation","volume":"33","author":"Zhang","year":"2022","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmc.2023.117456_b0055","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1021\/nn301282m","article-title":"Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo","volume":"6","author":"Huang","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.bmc.2023.117456_b0060","doi-asserted-by":"crossref","first-page":"e202114167","DOI":"10.1002\/anie.202114167","article-title":"Significance of receptor mobility in multivalent binding on lipid membranes","volume":"61","author":"Morzy","year":"2022","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmc.2023.117456_b0065","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1039\/D0CC02066D","article-title":"Self-assembly of chimeric peptides toward molecularly defined hexamers with controlled multivalent ligand presentation","volume":"56","author":"Yuan","year":"2020","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmc.2023.117456_b0070","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.4155\/tde.12.99","article-title":"Multivalent ligand: design principle for targeted therapeutic delivery approach","volume":"3","author":"Chittasupho","year":"2012","journal-title":"Ther Deliv"},{"key":"10.1016\/j.bmc.2023.117456_b0075","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1158\/1078-0432.CCR-20-3119","article-title":"FDA approval summary: accelerated approval of sacituzumab govitecan-hziy for third-line treatment of metastatic triple-negative breast cancer","volume":"27","author":"Wahby","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2023.117456_b0080","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1158\/1078-0432.CCR-16-2401","article-title":"Synthetic lethality exploitation by an anti\u2013trop-2-SN-38 antibody-drug conjugate, IMMU-132, plus PARP inhibitors in BRCA1\/2\u2013wild-type triple-negative breast cancer","volume":"23","author":"Cardillo","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2023.117456_b0085","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1021\/acs.bioconjchem.5b00223","article-title":"Sacituzumab govitecan (IMMU-132), an anti-trop-2\/SN-38 antibody-drug conjugate: characterization and efficacy in pancreatic, gastric, and other cancers","volume":"26","author":"Cardillo","year":"2015","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmc.2023.117456_b0090","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2174\/156802607780636690","article-title":"Carbonic anhydrases as drug targets - an overview","volume":"7","author":"Supuran","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2023.117456_b0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-444-63258-6.00010-X","article-title":"Tumor-associated carbonic anhydrases IX and XII","author":"Ondriskova","year":"2015","journal-title":"Carbonic Anhydrases as Biocatalysts"},{"key":"10.1016\/j.bmc.2023.117456_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104964","article-title":"Effect of Carbonic Anhydrase IX inhibitors on human endothelial cell survival","volume":"159","author":"Genah","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmc.2023.117456_b0105","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/14756366.2019.1579805","article-title":"Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells","volume":"34","author":"Koyuncu","year":"2019","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2023.117456_b0110","first-page":"1","article-title":"Carbonic anhydrases: catalytic and inhibition mechanisms, distribution and physiological roles","author":"Supuran","year":"2004","journal-title":"Carbonic Anhydrase Inhibitors Activators"},{"key":"10.1016\/j.bmc.2023.117456_b0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejpb.2016.09.018","article-title":"Inhibition of carbonic anhydrase IX in glioblastoma multiforme","volume":"109","author":"Amiri","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.bmc.2023.117456_b0120","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.bmcl.2004.01.095","article-title":"Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered","volume":"14","author":"Vullo","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117456_b0125","doi-asserted-by":"crossref","DOI":"10.1039\/C4SC00685B","article-title":"A bivalent small molecule-drug conjugate directed against carbonic anhydrase IX can elicit complete tumour regression in mice","volume":"5","author":"Krall","year":"2014","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmc.2023.117456_b0130","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1002\/anie.201310709","article-title":"A Small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors","volume":"53","author":"Krall","year":"2014","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmc.2023.117456_b0135","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1021\/am4017126","article-title":"Synthesis of d-mannose capped silicon nanoparticles and their interactions with MCF-7 human breast cancerous cells","volume":"5","author":"Ahire","year":"2013","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.bmc.2023.117456_b0140","doi-asserted-by":"crossref","first-page":"15216","DOI":"10.1002\/chem.201603294","article-title":"Tumour-targeted drug delivery with mannose-functionalized nanoparticles self-assembled from amphiphilic \u03b2-cyclodextrins","volume":"22","author":"Ye","year":"2016","journal-title":"Chem \u2013 A Eur J."},{"key":"10.1016\/j.bmc.2023.117456_b0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/acs.bioconjchem.8b00804","article-title":"Multivalency in drug delivery-when is it too much of a good thing?","volume":"30","author":"Tjandra","year":"2019","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmc.2023.117456_b0150","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1039\/D2CC03296A","article-title":"Design of high-avidity multivalent ligand structures that target cells with high ligand economy","volume":"58","author":"Fang","year":"2022","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmc.2023.117456_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.766932","article-title":"Probing multivalent carbohydrate-protein interactions with on-chip synthesized glycopeptides using different functionalized surfaces","volume":"9","author":"Tsouka","year":"2021","journal-title":"Front Chem"},{"key":"10.1016\/j.bmc.2023.117456_b0160","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1039\/D0SC01744B","article-title":"Precipitation-free high-affinity multivalent binding by inline lectin ligands","volume":"11","author":"Rohse","year":"2020","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmc.2023.117456_b0165","article-title":"Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2023.117456_b0170","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.drudis.2018.02.009","article-title":"Advances in glycosylation-mediated cancer-targeted drug delivery","volume":"23","author":"Cai","year":"2018","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2023.117456_b0175","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/bc500226j","article-title":"Dextran as a generally applicable multivalent scaffold for improving immunoglobulin-binding affinities of peptide and peptidomimetic ligands","volume":"25","author":"Morimoto","year":"2014","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmc.2023.117456_b0180","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1002\/anie.201410309","article-title":"Highly efficient synthesis of monodisperse poly(ethylene glycols) and derivatives through macrocyclization of oligo(ethylene glycols)","volume":"54","author":"Zhang","year":"2015","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmc.2023.117456_b0185","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1039\/C7RA12954H","article-title":"Maleimidation of dextran and the application in designing a dextran\u2013camptothecin conjugate","volume":"8","author":"Zhu","year":"2018","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2023.117456_b0190","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1016\/j.bmc.2018.08.008","article-title":"A series of camptothecin prodrugs exhibit HDAC inhibition activity","volume":"26","author":"Zhu","year":"2018","journal-title":"Bioorg Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:24:07Z","timestamp":1760837047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623003048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":38,"alternative-id":["S0968089623003048"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117456","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of multivalent drug delivery system with CA IX inhibitors as ligands","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117456"}}